A genetic model of vesicoureteral reflux and reflux nephropathy

描述(申请人提供)：膀胱输尿管反流(VUR-尿液从膀胱回流到输尿管)是儿童最常见的泌尿生殖系统异常，反流性肾病是儿童慢性肾功能衰竭的第四大原因。该应用程序广泛的长期目标是了解儿童膀胱输尿管反流和反流性肾病的病理生理学，最终提供最合适的治疗策略。为此，已经产生了一个小鼠系，这是一种新的膀胱输尿管反流的遗传模型。这些小鼠被命名为fgfr2Mes-/-(由于肾脏后肾间充质成纤维细胞生长因子受体2的条件性缺失)，经常在输尿管芽诱导部位(S)出现异常，这可能导致出生后小鼠输尿管返流的高发病率。许多患有持续性VUR(但没有明显的尿路感染)的成年fgfr2Mes-/-小鼠有疤痕形成，这与反流性肾病一致。这些小鼠有肌成纤维细胞转化的证据，与转化生长因子β(TGF-2)介导的损伤一致。我们的工作假设是，fgfr2Mes-/-小鼠代表了一种独特的膀胱输尿管反流和无菌反流性肾病的遗传模型，并且转化生长因子-2信号通路是介导反流性肾病肾损伤的关键分子途径。为了验证这一假设，已经产生了以下目标：特定目标1：阐明为什么fgfr2Mes-/-小鼠容易发生输尿管返流，检查输尿管、膀胱和输尿管-膀胱(输尿管膀胱)交界处的形成。具体目标2：完整描述fgfr2Mes-/-小鼠VUR和反流性肾病的自然病史。具体目标3：阐明异常的转化生长因子-2信号在反流性肾病进展中的作用，包括其作为治疗靶点的作用。这种独特的小鼠模型将允许仔细评估膀胱输尿管反流和反流性肾病的病理生理学，这将为患有这些疾病的儿童提供新的治疗策略。 公共卫生相关性： 膀胱输尿管返流(尿液从膀胱回流到输尿管，流向肾脏)是最常见的尿路出生缺陷。这通常会导致反流性肾病，这是导致儿童肾衰竭的主要原因。我们有一个小鼠突变，它会发展成反流和随后的反流性肾病。这个小鼠模型将帮助我们确定如何最好地治疗患有这种疾病的儿童。

DESCRIPTION (provided by applicant): Vesicoureteral reflux (VUR- backflow of urine from the bladder into the ureter) is the most common urogenital anomaly in children and reflux nephropathy is the 4th leading cause of chronic renal failure in children. The application's broad long-term objectives are to understand the pathophysiology of vesicoureteral reflux and reflux nephropathy in children to ultimately offer the most appropriate treatment strategies. To that end, a mouse line has been generated that is a novel genetic model of vesicoureteral reflux. The mice, designated fgfr2Mes-/- (due to conditional deletion of fibroblast growth factor receptor 2 from kidney metanephric mesenchyme), frequently have abnormalities in ureteric bud induction site(s), which likely leads to the high incidence of VUR in young post natal mice. Many adult fgfr2Mes-/- mice with persistent VUR (but no obvious urinary tract infections) have scarring, consistent with reflux nephropathy. These same mice have evidence of myofibroblast transformation consistent with transforming growth factor beta (TGF-2) mediated injury. It is our working hypothesis that the fgfr2Mes-/- mice represent a unique genetic model of vesicoureteral reflux and sterile reflux nephropathy, and that TGF-2 signaling is a key molecular pathway mediating renal injury in reflux nephropathy. To test this hypothesis, the following aims have been generated: Specific Aim 1: Elucidate why the fgfr2Mes-/- mice are prone to VUR, examining formation of the ureter, bladder and ureter-bladder (ureterovesicle) junction. Specific Aim 2: Completely characterize the natural history of VUR and reflux nephropathy in fgfr2Mes-/- mice. Specific Aim 3: Elucidate the role of aberrant TGF-2 signaling in the progression of reflux nephropathy, including its utility as a therapeutic target. This unique mouse model will permit careful evaluation of the pathophysiology of vesicoureteral reflux and reflux nephropathy, which should provide novel therapeutic strategies for children with these conditions. PUBLIC HEALTH RELEVANCE: Vesicoureteral reflux (backflow of urine from the bladder into the ureter toward the kidney) is the most common urinary tract birth defect. This often leads to reflux nephropathy, a leading cause of kidney failure in children. We have a mouse mutant that develops reflux and subsequent reflux nephropathy. This mouse model will help us determine how best to treat children with this condition.